Stalling Need for ADT in Recurrent Prostate Cancer

]]>(MedPage Today) -- SAN FRANCISCO--Immediate treatment of limited metastatic recurrence of prostate cancer led to a fourfold improvement in the proportion of patients alive without androgen deprivation therapy (ADT) at 5 years, according to...